Olympus launches “Olympus Asia Pacific Innovation Program”, an acceleration program for start-up companies in the medical device field
Supporting next generation innovative solutions to improve standards of care
Olympus Corporation (hereafter, Olympus) has established MedTech Innovator Asia Pacific, a non-profit organization that supports start-up companies in medical equipment, diagnostics, and digital health, as part of efforts to continue Olympus’ history of innovation. With the cooperation of Asia Pacific (hereinafter referred to as MedTech Innovator), the acceleration program “Olympus Asia Pacific Innovation Program (https://medtechinnovator.org/olympusapac2023/)” will start on December 5, 2022. Through this program, Olympus aims to support the next generation of innovative solutions to improve the standard of care.
In this program, from May to September 2023, Olympus will target start-up companies with innovative technologies that contribute to minimally invasive treatment and the detection, diagnosis, and treatment of lesions in the field of medical devices. We will have two pitch events. The grand prize winner will receive a mentorship program by Olympus and a cash prize of US$75,000.
Based on our corporate philosophy of “realizing the health, peace of mind, and spiritual well-being of people around the world,” Olympus aims to improve the standard of medical care for patients. We have provided various products and solutions for 100*2 diseases, including the treatment of *1 (lung cancer, stomach cancer, colorectal cancer, and prostate cancer). Olympus believes that the emergence of new technologies, especially digital solutions, will significantly change the paradigm of patient care. We will contribute to improving patient outcomes by building solutions that are suitable for each patient and optimizing each step of the series of medical care processes. [Image 1
*1 As of March 2022. Source: GLOBOCAN2020 Excludes breast cancer, which is the number one patient.
*2 As of March 2022.
Felicia Chung, Olympus Asia Pacific Regional Business Development Leader, said, “We are pleased to be the first Olympus to launch an acceleration program in the medical device field. The Asia Pacific region is particularly innovating in the area of digital solutions. Through this program, Olympus will find technologies that create tangible value for healthcare professionals and patients, and develop next-generation solutions that contribute to minimally invasive treatments and lesion detection, diagnosis, and treatment. We will continue to support the
Marc Radatt, CEO of Olympus Corporation of Asia Pacific Limited and Board member of the Asia Pacific Medical Technology Association, said: “We are proud to partner with MedTech Innovator to support emerging technologies that will revolutionize patient outcomes. It will contribute to the further development of medical technology as a whole.”
■ Participation criteria
A start-up company developing solutions that play an important role in establishing new methods for minimally invasive treatment and lesion detection, diagnosis and treatment for cancers and diseases, especially in the gastrointestinal, respiratory and urological fields. Below is an example.
・Smart endoscopic diagnosis and treatment: Enables early detection and advanced endoscopic treatment
・ Robotics, sensing, monitoring and navigation technologies for future autonomy in minimally invasive diagnostics, surgery and treatment ・ Transformation of a series of medical care processes from
pre-surgery to post-surgery
– AI technology for clinical efficiency and predictive analysis – 3D and 4D image processing in surgical treatment
・ New devices and solutions to replace current surgery and drug treatments ・ Innovative technologies that enable non-invasive or minimally invasive diagnosis, surgery and treatment
・ Ethical AI and digital technology
・ Next generation automatic documentation
・ Smart diagnosis and remote patient monitoring in the gastrointestinal field ■ About MedTech Innovator
Based in Los Angeles, California, MedTech Innovator is a
not-for-profit organization that supports startups as accelerators for the world’s largest medical device companies. Its mission is to improve the lives of patients by accelerating the growth of companies transforming the healthcare industry. MedTech Innovator provides guidance and support by matching leading companies in the medical industry with innovative technology start-ups and ventures. For more information about MedTech Innovator, please visit
https://medtechinnovator.org/, Twitter @MedTechAwards and LinkedIn MedTech Innovator
(https://www.linkedin.com/company/medtech-innovator/mycompany/). And for more information on current and past MedTech Innovator
participants and industry insights, subscribe to our monthly newsletter.
For more information on the Olympus Asia Pacific Innovation Program 2023, please see here (https://medtechinnovator.org/olympusapac2023/). Company names and product names in this release are trademarks or registered trademarks of their respective companies.
As a leading medtech company, Olympus’ medical field has progressed together with medical professionals with innovative technology and manufacturing technology. In diagnosis and minimally invasive treatment, we will produce better clinical results, bring benefits to the medical economy, and contribute to improving the health and quality of life of people around the world.
Our product portfolio in the medical field offers a wide range of products and services, from flexible endoscopes, rigid endoscopes, video imaging systems, to surgical devices, system integration, repair services, and a lineup of diagnostic and therapeutic instruments. doing. For more information, please visit www.olympus.co.jp/. Also, please follow Olympus’ official Twitter.
Details about this release: